Long-term stability of transconjunctival midface lift surgery for postblepharoplasty lower eyelid retraction.


Journal

Journal of plastic, reconstructive & aesthetic surgery : JPRAS
ISSN: 1878-0539
Titre abrégé: J Plast Reconstr Aesthet Surg
Pays: Netherlands
ID NLM: 101264239

Informations de publication

Date de publication:
07 2022
Historique:
received: 04 11 2021
revised: 11 12 2021
accepted: 13 02 2022
pubmed: 25 3 2022
medline: 14 7 2022
entrez: 24 3 2022
Statut: ppublish

Résumé

Lower eyelid retraction occurring as a complication of lower eyelid blepharoplasty may give rise to symptoms of exposure keratitis as well as cosmetic considerations. This retrospective longitudinal study describes our clinical experience with 74 patients with bilateral lower eyelid retraction postblepharoplasty (148 eyes) undergoing a transconjunctival subperiosteal midface lift with the implantation of a hard palate spacer graft over the period 2002 to 2019. All patients had a forced-up traction test result of less than or equal to 2 mm, indicating a significant fibrosis of the middle lamellae. Margin reflex distances (MRD2) were examined at follow-up visits scheduled for 2 weeks, 1 month, and 1, 3, 6, 9, and 12 years. Mean follow-up duration was ± 102 months (range 6 to 144 months). In all patients, MRD2 varied up until 1-year postsurgery and stabilized thereafter. Last follow-up MRD2 values indicated retraction improvements of 1.4, 2.4, and 3.2 mm, respectively, for those with mild: MRD2 6.3 mm [5.5 - 6.6], moderate: 7.0 mm [6.7 - 7.8], and severe retraction: 8.5 mm [7.9 - 9]. This improvement was statistically significant in patients with severe baseline retraction (p = 0.04). This approach proved to be safe and functional, and cosmetic results were excellent and remained stable over time.

Identifiants

pubmed: 35321816
pii: S1748-6815(22)00122-X
doi: 10.1016/j.bjps.2022.02.042
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2346-2351

Informations de copyright

Copyright © 2022 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Auteurs

Juan Carlos Sánchez-España (JC)

Hospital Clínic de Barcelona, oculoplastic surgery department, Barcelona, Spain.

Luz María Vasquez (LM)

Instituto de Microcirugía Ocular, IMO, oculoplastic surgery department, Barcelona, Spain.

Francisco Zamorano-Martín (F)

Hospital Regional Universitario de Málaga, ophthalmology department, Málaga, Spain. Electronic address: Zamoranomartinfrancisco@gmail.com.

Max Junior Rondón-Benavente (MJ)

Clínica Sagrada Familia, oculoplastic surgery department, Barcelona, Spain.

Ramón Medel (R)

Instituto de Microcirugía Ocular, IMO, oculoplastic surgery department, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH